Deadline: 22-Jun-2026
The Centers for Disease Control and Prevention (CDC) has announced a funding opportunity to strengthen tuberculosis (TB) prevention, diagnosis, treatment, and surveillance across Asia, with a particular focus on India, the Philippines, and Vietnam. The initiative seeks to reduce TB-related illness and deaths through innovative, evidence-based interventions that improve access to prevention, testing, treatment, and public health surveillance systems.
With an expected first-year funding pool of $3 million, the program aims to support organizations that can advance TB control efforts, strengthen health systems, and improve outcomes for populations most affected by tuberculosis and drug-resistant TB.
About the Funding Opportunity
Tuberculosis remains one of the world’s leading infectious disease threats, with Asia carrying the highest burden of TB and drug-resistant TB cases globally. Despite significant progress in TB control, many individuals remain undiagnosed, untreated, or diagnosed too late, contributing to ongoing transmission and poor health outcomes.
Through this funding opportunity, CDC seeks to support projects that strengthen the entire TB care continuum, from prevention and early detection to treatment and surveillance.
The program encourages innovative approaches that can improve access to services, increase treatment success, and strengthen public health responses.
Program Objectives
The initiative focuses on several key priorities:
- Strengthening TB case finding
- Expanding TB screening and testing services
- Improving diagnostic evaluation and early detection
- Increasing access to TB preventive treatment (TPT)
- Enhancing linkage to care and treatment services
- Improving treatment outcomes for active TB disease
- Strengthening surveillance and data systems
- Supporting evidence-based decision-making
- Expanding diagnosis of drug-resistant and multidrug-resistant TB
- Improving public health responses to TB outbreaks
Projects should demonstrate how proposed activities contribute to reducing TB transmission, illness, and mortality.
Priority Areas
Tuberculosis Case Finding and Diagnosis
A major focus of the program is identifying individuals with TB earlier and connecting them to appropriate care.
Supported activities may include:
- Community-based TB screening
- Diagnostic testing initiatives
- Early case detection strategies
- Improved referral systems
- Expansion of laboratory services
- Identification of asymptomatic TB cases
- Detection of drug-resistant TB
- Detection of multidrug-resistant TB (MDR-TB)
Early diagnosis remains one of the most effective ways to reduce disease transmission and improve treatment outcomes.
Tuberculosis Prevention
The program supports efforts to prevent TB disease among individuals at increased risk.
Priority activities may include:
- Expansion of TB preventive treatment (TPT)
- Identification of high-risk populations
- Screening for TB infection
- Preventive care services
- Community awareness and prevention initiatives
Strengthening preventive treatment can significantly reduce the risk of progression from TB infection to active disease.
Tuberculosis Treatment
Applicants are encouraged to improve access to effective and patient-centered treatment services.
Activities may include:
- Strengthening treatment linkage and follow-up
- Improving treatment adherence
- Expanding access to newer treatment regimens
- Supporting shorter and better-tolerated treatment options
- Managing drug-resistant TB cases
- Improving patient outcomes through integrated care approaches
Special attention is encouraged for individuals affected by drug-resistant and multidrug-resistant TB.
TB Surveillance and Data Systems
Strong surveillance systems are essential for effective TB control.
Projects may focus on:
- Strengthening TB surveillance systems
- Improving data collection and reporting
- Enhancing data analysis capabilities
- Supporting evidence-based policy development
- Improving monitoring and evaluation systems
- Strengthening public health decision-making
Enhanced surveillance can help health authorities respond more effectively to changing disease trends.
Funding Information
The funding opportunity will be awarded through a cooperative agreement mechanism.
Funding details include:
- Total anticipated first-year funding: $3 million
- Expected number of awards: 1 to 3
- Average annual funding request: Up to $1 million per award
- Project duration: Up to five years
- Continued funding subject to available funds, satisfactory performance, and federal priorities
Applicants should submit realistic budgets aligned with proposed project activities and expected outcomes.
Eligible Countries
Applicants must propose activities in one of the following countries:
- India
- Philippines
- Vietnam
Each application should focus on a single eligible country.
Who Can Apply?
Eligibility is unrestricted and open to a wide range of organizations.
Eligible applicants include:
- Government agencies
- Academic institutions
- Universities and research organizations
- Nonprofit organizations
- Private sector entities
- Small businesses
- Tribal organizations
- International organizations
- Foreign entities
- Non-U.S.-based organizations
Organizations should demonstrate the technical expertise and operational capacity necessary to implement large-scale TB programs.
Expected Impact
The program seeks to generate measurable improvements in:
- TB prevention coverage
- Early case detection
- Diagnostic access
- Treatment success rates
- Drug-resistant TB management
- Surveillance quality
- Public health preparedness
- Evidence-based policy development
Successful projects should contribute to stronger national TB programs and more resilient health systems.
Why This Funding Matters
Tuberculosis remains a major public health challenge, particularly in countries with high disease burdens. Drug-resistant TB continues to threaten global health progress and requires innovative approaches to diagnosis, treatment, and prevention.
This CDC investment aims to:
- Reduce TB-related illness and deaths
- Strengthen national TB control programs
- Improve access to quality healthcare services
- Enhance surveillance and monitoring systems
- Support innovation in TB prevention and treatment
- Build stronger public health infrastructure
- Advance global TB elimination efforts
By supporting evidence-based interventions, the initiative contributes to healthier communities and stronger health systems across Asia.
Frequently Asked Questions
- What is the goal of the CDC TB funding opportunity?
The program aims to strengthen tuberculosis prevention, diagnosis, treatment, and surveillance in Asia to reduce TB-related morbidity and mortality. - Which countries are eligible under this funding opportunity?
Projects must focus on India, the Philippines, or Vietnam. - How much funding is available?
CDC expects to provide approximately $3 million in first-year funding, with individual awards averaging up to $1 million annually. - How many awards will be made?
CDC anticipates making between one and three awards. - Who can apply?
Government agencies, academic institutions, nonprofits, private organizations, small businesses, tribal organizations, and foreign entities are eligible. - What types of TB activities are supported?
Activities may include TB screening, diagnosis, preventive treatment, patient care, drug-resistant TB management, surveillance strengthening, and data system improvements. - How long can funded projects last?
Projects may receive support for up to five years, depending on funding availability and project performance.
Conclusion
The CDC Tuberculosis Prevention, Diagnosis, Treatment, and Surveillance Program represents a significant investment in strengthening TB control efforts across Asia. With funding of up to $1 million annually per award and a potential project period of five years, the initiative supports innovative and evidence-based approaches to preventing TB, improving diagnosis and treatment outcomes, and strengthening surveillance systems. By focusing on India, the Philippines, and Vietnam, the program aims to reduce the burden of tuberculosis while advancing stronger and more resilient public health systems throughout the region.
For more information, visit Grants.gov.